Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
Retrieved on:
Thursday, July 6, 2023
Self-funded medical research organisation and charity, LifeArc, to launch a groundbreaking Rare Disease Translational Challenge that will invest more than £100m by 2030 to improve the lives of people living with a rare disease.
Key Points:
- Self-funded medical research organisation and charity, LifeArc, to launch a groundbreaking Rare Disease Translational Challenge that will invest more than £100m by 2030 to improve the lives of people living with a rare disease.
- The first commitment will be £40m for the creation of up to five Translational Rare Disease Centres across the UK that will specialise in different aspects of rare disease research.
- The Rare Disease Translational Challenge will be a game-changer for people living with a rare disease.”
Catriona Crombie, Head of Rare Disease Translational Challenge at Life Arc, said: “Through our Rare Disease Translational Challenge, we will leverage our expertise in drug discovery, diagnostics, and translational science. - In the 2023 England Rare Diseases Action Plan we highlighted our ongoing commitment to investment in rare disease research through the NIHR MRC Rare Disease Research Platform and renewed investment in the NIHR Biomedical Research Centres.